scispace - formally typeset
V

Vanessa Cropley

Researcher at University of Melbourne

Publications -  110
Citations -  3631

Vanessa Cropley is an academic researcher from University of Melbourne. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 26, co-authored 91 publications receiving 2530 citations. Previous affiliations of Vanessa Cropley include National Institutes of Health & Monash University.

Papers
More filters
Journal ArticleDOI

Widespread white matter microstructural differences in schizophrenia across 4322 individuals : results from the ENIGMA Schizophrenia DTI Working Group

Sinead Kelly, +191 more
- 01 May 2018 - 
TL;DR: The present study provides a robust profile of widespread WM abnormalities in schizophrenia patients worldwide, and is believed to be the first ever large-scale coordinated study of WM microstructural differences in schizophrenia.
Journal ArticleDOI

Molecular imaging of the dopaminergic system and its association with human cognitive function.

TL;DR: Although associations between DA and cognitive measures need to be considered within the context of fronto-striato-thalamic circuitry, it is suggested that striatal DA activity, particularly via D2 receptors, might be important for response inhibition, temporal organization of material, and motor performance, whereas cortical DA transmission via D1 receptors might beimportant for maintaining and representing on-going behavior.
Journal ArticleDOI

Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.

TL;DR: In monkey and rat, 3 and 10 were rapidly metabolized by ester hydrolysis and N-debenzylation, respectively, each to a single polar radiometabolite, and are effective for imaging PBR in monkey brain.
Journal ArticleDOI

Microglial activation and progressive brain changes in schizophrenia.

TL;DR: Evidence for microglial dysfunction in schizophrenia is reviewed from both neuroimaging and neuropathological data, with a specific focus on studies examining microglia activation in relation to the pathology of grey and white matter.
Journal ArticleDOI

Accelerated Gray and White Matter Deterioration With Age in Schizophrenia

TL;DR: The findings suggest that schizophrenia is characterized by an initial, rapid rate of gray matter loss that slows in middle life, followed by the emergence of a deficit in white matter that progressively worsens with age at a constant rate.